Nektan PLC Q&A: BetVictor contract & new CEO (LON:NKTN)
18 October 2018
In the dynamic landscape of regenerative medicine, Organogenesis Holdings Inc. (NASDAQ: ORGO) is carving a niche with its innovative portfolio targeting advanced wound care and surgical applications. With a market..
Kamada Ltd. (NASDAQ: KMDA), a prominent player in the healthcare sector, specializes in manufacturing plasma-derived protein therapeutics. Headquartered in Rehovot, Israel, Kamada’s diverse product portfolio addresses various critical medical needs,..
Treace Medical Concepts, Inc. (NASDAQ: TMCI), a pioneering company in the healthcare sector, specifically within the medical devices industry, has been capturing investor attention with its innovative solutions for bunion..
For investors with a keen eye on the biotechnology sector, Rapport Therapeutics, Inc. (NASDAQ: RAPP) presents a compelling opportunity, particularly with a projected potential upside of 70.80%. The Boston-based clinical-stage..
Tyra Biosciences, Inc. (NASDAQ: TYRA), a clinical-stage biotechnology firm, is capturing the attention of investors with its notable potential upside of 57.33%, according to analyst ratings. With a market capitalization..
Celcuity Inc. (NASDAQ: CELC), a clinical-stage biotechnology company, is making waves in the healthcare sector with its innovative approach to cancer treatment. With a market capitalization of $4.94 billion, Celcuity..
AnaptysBio, Inc. (NASDAQ: ANAB), a clinical-stage biotechnology company headquartered in San Diego, California, is capturing investor attention with an enticing 22.46% potential upside, as indicated by the latest analyst ratings...
Bioventus Inc. (NASDAQ: BVS), a prominent player in the healthcare sector, specifically within the medical devices industry, has caught the eye of investors with a robust potential upside of 69%..
Kura Oncology, Inc. (NASDAQ: KURA), a clinical-stage biopharmaceutical company based in San Diego, California, is gaining significant attention from investors with its potential for substantial upside. As a key player..
Trevi Therapeutics, Inc. (NASDAQ: TRVI) emerges as a compelling player in the biotechnology sector with its focus on pioneering treatments for chronic cough and pruritus. The company, headquartered in New..
Investors eyeing the biotechnology sector may find Prothena Corporation plc (NASDAQ: PRTA) a compelling prospect, thanks to its significant upside potential and thriving pipeline in neurodegenerative disease therapeutics. Based in..
For investors with a keen eye on biotechnology stocks, Verastem, Inc. (NASDAQ: VSTM) presents a particularly intriguing opportunity within the healthcare sector. With a market capitalization of $447.4 million, this..
Rocket Pharmaceuticals, Inc. (RCKT) is a promising player in the biotechnology sector, focusing on the development of transformative gene therapies for rare and devastating diseases. With a market capitalization of..
Orthofix Medical Inc. (NASDAQ: OFIX), a key player in the healthcare sector specializing in medical devices, presents a compelling opportunity for investors eyeing growth in the medical technology space. With..
AtaiBeckley Inc. (NASDAQ: ATAI), a rising star in the biotechnology sector, is capturing investor attention with its groundbreaking approach to mental health treatments. Specializing in the research and development of..
Personalis, Inc. (PSNL), a prominent player in the healthcare sector’s diagnostics and research industry, is gaining attention for its innovative cancer genomic tests and services. With a market cap of..
Humacyte, Inc. (NASDAQ: HUMA), a burgeoning player in the biotechnology sector, has captured the attention of investors with its innovative approach to healthcare solutions. Specializing in bioengineered human tissues, Humacyte..
Precigen, Inc. (NASDAQ: PGEN) has recently captured the attention of investors due to its significant growth potential within the biotechnology sector. The company, headquartered in Germantown, Maryland, is at the..
AbCellera Biologics Inc. (NASDAQ: ABCL), a prominent player in the biotechnology sector, is making waves with its robust pipeline of antibody-based medicines developed to address unmet medical needs. Headquartered in..
Cel-Sci Corporation (NASDAQ: CVM), a clinical-stage biotechnology company, has captured the attention of investors with its promising immunotherapy developments and impressive potential upside. With a market capitalization of $40.7 million,..
